Workflow
CNBC Television
icon
Search documents
Lightning Round: Arcus Biosciences is speculative, it's too risky to fully bank on, says Jim Cramer
CNBC Television· 2025-08-14 00:13
It is time. It's time for the white girls and then the lightning round is over. Are you ready to eat that right George in New York.George, hey Jim, thank you for taking my call. Of course, George. What's happening.My my mother's been battling clear cell renal cell carcinoma for the last five years. I know that hits close to home for you and your family as well. So, I'm sorry that you've had to experience that.I'm calling in today about a company called Arcus Biosciences. They're pioneering breakthrough canc ...
Cramer dives into the IPO market and whether investors should be bullish on Bullish
CNBC Television· 2025-08-13 23:51
Hey, I'm Kramer. Welcome to Mad Money. Welcome to Crime America.Other people, my friends. I'm just trying to help make some money. My job is not just to put in context, but to entertain, to teach.Call me 1800743 CBC. Tweet me, Jim Kramer. This market isn't unprecedented, but I honestly haven't seen anything like it since back in the 80s and 90s.In those days, money roved Wall Street like a gang of thugs, beating up, taking over sectors, relentlessly searching for big game, always on the lookout for the next ...
Cramer: There's a mad dash to make money anywhere in the market right now
CNBC Television· 2025-08-13 23:47
This market isn't unprecedented, but I honestly haven't seen anything like it since back in the 80s and 90s. In those days, money roved Wall Street like a gang of thugs, beating up, taking over sectors, relentlessly searching for big game, always on the lookout for the next getrich thing. And that's where we are right now at this moment with the Dow gaining another 464 points today.S&B climbing.32%. The NASDAQ just advancing.14%. NASDAQ has too much data center which was weaker today.Bear with me on that. R ...
Mad Money 8/13/25 | Audio Only
CNBC Television· 2025-08-13 23:44
Listen to Jim Cramer’s personal guide through the confusing jungle of Wall Street investing, navigating through opportunities and pitfalls with one goal in mind - to help you make money. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Watch CNBC on the go with CNBC+: https://www.cnbc.com/WatchCNBCPlus Turn to CNBC TV for the latest stock market new ...
Nasdaq CEO on being honored by the New York Fire Department
CNBC Television· 2025-08-13 23:38
We do want to talk to you about a special event in September which you will be honored. Um can you tell us about it. >> Yeah, so the fire department of New York Foundation, it is the foundation that the official foundation to the New York Fire Department as we all know the New York Firefighters are the true heroes in our city. I mean they and we have the best fire department in the world in my opinion here in New York and they work selflessly every single day to serve our community.And the foundation, what ...
Final Trade: KWEB, PNFP, BABA & NDAQ
CNBC Television· 2025-08-13 22:19
Time for the final trade. Tim Seymour. >> What if guy's beauty consultant knows he's got a leaky fountain.Um anyway, I know that K web and investment in Chinat is beautiful and I would stay along that trade. >> Karen, yes. In the regional bank space, Pinnacle Financial Partners.And I do like this novice merger. >> Dan. >> Yeah.Like Tim, I think you stick with the B in guy's tube. That would be Baba. Guy looks like he wants to what.>> Party. And it's the A in carved. Come on.>> Obviously. Yes. >> A few thing ...
Insmed CEO on what’s next for company after FDA greenlights lung disease drug
CNBC Television· 2025-08-13 22:15
Welcome back to Fast Money Insad trading at highs not seen in a quarter of a century after the company clinched FDA approval for its first-in-class drug treating a form of chronic lung disease. The company estimating the drug could top $5 billion in peak sales for this indication alone with a patient population of as many as 500,000 in the US. Joining us on the set for more is INSMAD CEO Will Lewis.Will, welcome back. Congratulations on the FDA approval. This is the first DPP1 inhibitor for non-cystic fibro ...
Nasdaq CEO on IPO market comeback, stock strength and AI adoption
CNBC Television· 2025-08-13 22:06
Welcome back to Fast Money. The stock behind the NASDAQ composite on a tear. The NDAQ hitting all-time highs this week.It is up more than 23% this year, far outpacing its namesake index. While the composite notched record record intraday and closing highs today, it's only up 12% to discuss what is driving the exchange and its business. Let's bring in NASDAQ chair and CEO Adena Freedman.>> Oh, we got to clap Adena in. I mean, we certain people our landlord. >> Exactly.Our landlord. Um Adena, great to see you ...
What’s next for rates as investors digest inflation data
CNBC Television· 2025-08-13 21:37
All right, let's get more on where rates could be headed with CNBC's own Rick Santelli. Rick, it is great to see you. Um, I want to start off with where where Tim um sort of left off in terms of we're not the only player in terms of dictating where rates go.There's a whole global uh rates market. The German 30year, for instance, hit its highest since 2011 just yesterday. So, there's a whole other dynamic going on.Where do you see rates headed if we are to be lower by 150 basis points. Well, I have some char ...
Warren Buffett no longer one of top 10 richest people in the world
CNBC Television· 2025-08-13 21:24
Warren Buffett is no longer one of the top 10 richest people in the world. According to the Bloomberg Billionaires Index, the Oracle of Omaha is now in the number 11 spot with a 141 billion net worth. Since he announced his retirement in May, Bergkshire Hathway has lagged the S&P 500 by nearly 25 percentage points.Buffett's also part of the Giving Pledge, which is a group of billionaires who promised to give away a majority of their wealth. He also dropped down on the list because other billionaires have ju ...